Consideration of Pneumonectomy in the Era of Chemo-Immunotherapy in Resectable NSCLC
The Thoracic and Cardiovascular Surgeon Reports · 01.01.2025 · 14 (01) · e1-e3
DOI: 10.1055/a-2564-2186 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Thoracic and Cardiovascular Surgeon Reports, erschienen am 01.01.2025. Verfasst von Ibrahim Azar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Trinity Health IHA Medical Group Oakland Campus, Pontiac, United States. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Trinity Health IHA Medical Group Oakland Campus, Pontiac, United States.
- Department of Medicine, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States.
- Department of Surgery, University of California Irvine School of Medicine, Orange, California, United States.
- Department of Oncology, University of California Irvine School of Medicine, Orange, California, United States.
ORCID-Profile: Misako Nagasaka
Zitieren
APA
Azar, I., Vojjala, N., Parikh, R., Keshava, H. B., & Nagasaka, M. (2025). Consideration of Pneumonectomy in the Era of Chemo-Immunotherapy in Resectable NSCLC. The Thoracic and Cardiovascular Surgeon Reports, 14(01), e1-e3. https://doi.org/10.1055/a-2564-2186
Vancouver
Azar I, Vojjala N, Parikh R, Keshava HB, Nagasaka M. Consideration of Pneumonectomy in the Era of Chemo-Immunotherapy in Resectable NSCLC. The Thoracic and Cardiovascular Surgeon Reports. 2025;14(01):e1-e3. doi:10.1055/a-2564-2186
BibTeX
@article{Azar2025,
author = {Azar, Ibrahim and Vojjala, Nikhil and Parikh, Richa and Keshava, Hari B and Nagasaka, Misako},
title = {Consideration of Pneumonectomy in the Era of Chemo-Immunotherapy in Resectable NSCLC},
journal = {The Thoracic and Cardiovascular Surgeon Reports},
year = {2025},
volume = {14},
number = {01},
pages = {e1--e3},
doi = {10.1055/a-2564-2186}
}
EUVIMED